DORICOMB

This brand name is authorized in Poland.

Active ingredients

The drug DORICOMB contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Benzalkonium chloride UNII `F5UM2KM3W7` - BENZALKONIUM CHLORIDE
	Read more about Benzalkonium chloride
`2`	Benzocaine UNII `U3RSY48JW5` - BENZOCAINE
	Benzocaine is a local anaesthetic of the ester type, acting to produce reversible loss of sensation by preventing or diminishing the generation and transmission of sensory nerve impulses near the site of application. Depolarisation of the neuronal membrane and ion exchange are reversibly inhibited.
	Read more about Benzocaine
`3`	Tyrothricin UNII `877376V2XW` - TYROTHRICIN
	Tyrothricin is a circular polypeptide with antibiotic and bacteriostatic activity. It is effective against gram-positive bacteria.
	Read more about Tyrothricin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R02AA20	Various	R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AA Antiseptics
Discover more medicines within R02AA20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
PL	Rejestru Produktów Leczniczych	100425104

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.